Teizeild 2 mg/2 mL
Teizeild 2 mg/2 mL is a medicine authorised by Swissmedic under authorisation number 70102. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 May 2026 and the authorisation is limited until 20 May 2031. ATC code A10XX01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 70102 |
|---|---|
| Name | Teizeild 2 mg/2 mL |
| Full name | Teizeild 2 mg/2 mL, solution à diluer pour perfusion |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A10XX01 |
| First authorisation | 21 May 2026 |
| Authorisation validity | 20 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Teizeild 2 mg/2 mL, solution à diluer pour perfusion | A | 21 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | A10XX01 | 07.06. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Teizeild 2 mg/2 mL authorised in Switzerland?
Yes. Teizeild 2 mg/2 mL is authorised by Swissmedic under authorisation number 70102, data as of 01 September 2026. The authorisation is limited until 20 May 2031.
Which dispensing category does Teizeild 2 mg/2 mL have?
Teizeild 2 mg/2 mL is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Teizeild 2 mg/2 mL?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.